Literature DB >> 14566937

A simple way of quantifying immunostained cell nuclei on the whole histologic section.

Nicolas Elie1, Benoît Plancoulaine, Jehan-Pierre Signolle, Paulette Herlin.   

Abstract

BACKGROUND: Quantification of nuclei, immunostained for proliferation or differentiation markers, is widely recommended for prognostication and treatment of numerous solid tumors. However, many problems concerning reproducibility of the results obtained still remain, partially due to the lack of standardization of the method used and to the difficulty of taking into account tumor tissue heterogeneity. Technical solutions exist but they are expensive and time consuming, and their complexity limits their diffusion in routine pathology departments.
METHODS: In the present study, we use a simple, fast and inexpensive system of acquisition, a 4,000 dots-per-inch slide scanner, to get a single true color numerical image of the whole histologic section. The analysis is done thanks to fully automatic image processing, allowing computation of the stain proportion on the whole histologic section, as well as in "hot spots."
RESULTS: After having precisely fixed settings of the slide scanner, one can easily detect counterstained and immunostained structures, by image analysis. This simple and stable processing can be done under 6 min.
CONCLUSIONS: The association of immunohistochemistry, stable acquisition device and computer-assisted image analysis provides an objective, reproducible, and easy to standardize quantification of the nuclear markers, in relation to the total tumor tissue architecture. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566937     DOI: 10.1002/cyto.a.10075

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  13 in total

1.  Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

Authors:  Wenjin Chen; David J Foran
Journal:  Anal Chim Acta       Date:  2006-01-23       Impact factor: 6.558

2.  Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal PET studies: an example with cell proliferation, glucose transporter 1 and FDG.

Authors:  Nicolas Aide; Alexandre Labiche; Paulette Herlin; Maria Paciencia; Laurent Poulain; Soizic Dutoit; Françoise Montravers; Pascal Gauduchon; Jacques Chasle
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

3.  Changes in elastin density in different locations of the vaginal wall in women with pelvic organ prolapse.

Authors:  Laurent de Landsheere; Silvia Blacher; Carine Munaut; Betty Nusgens; Chrystèle Rubod; Agnès Noel; Jean-Michel Foidart; Michel Cosson; Michelle Nisolle
Journal:  Int Urogynecol J       Date:  2014-05-28       Impact factor: 2.894

4.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

5.  Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.

Authors:  Ariane Galaup; Aurelie Cazes; Sebastien Le Jan; Josette Philippe; Elisabeth Connault; Emmanuelle Le Coz; Halima Mekid; Lluis M Mir; Paule Opolon; Pierre Corvol; Catherine Monnot; Stephane Germain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

6.  Ki-67 is a reliable pathological grading marker for neuroendocrine tumors.

Authors:  Ashlie Nadler; Moises Cukier; Corwyn Rowsell; Sepideh Kamali; Yael Feinberg; Simron Singh; Calvin H L Law
Journal:  Virchows Arch       Date:  2013-04-16       Impact factor: 4.064

7.  Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.

Authors:  Nicolas Aide; Laurent Poulain; Mélanie Briand; Soizic Dutoit; Stéphane Allouche; Alexandre Labiche; Aurélie Ngo-Van Do; Valérie Nataf; Alain Batalla; Pascal Gauduchon; Jean-noël Talbot; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

8.  Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.

Authors:  Claire Magnon; Paule Opolon; Marcel Ricard; Elisabeth Connault; Patrice Ardouin; Ariane Galaup; Didier Métivier; Jean-Michel Bidart; Stéphane Germain; Michel Perricaudet; Martin Schlumberger
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description.

Authors:  C Balsat; S Blacher; N Signolle; A Beliard; C Munaut; F Goffin; A Noel; J M Foidart; F Kridelka
Journal:  ISRN Obstet Gynecol       Date:  2011-08-25

10.  The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.

Authors:  Yamina Hamma-Kourbali; Oya Bermek; Isabelle Bernard-Pierrot; Racha Karaky; Dominique Martel-Renoir; Sophie Frechault; José Courty; Jean Delbé
Journal:  BMC Cancer       Date:  2011-05-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.